-
FDA approves Novartis drug for rare blood disorder
SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for removing excess iron from the blood in patients with a rare genetic disorder, the agency said.
The FDA announced the approval of Novartis' Exjade (deferasirox) for patients ages 10 years and older with chronic iron overload resulting from nontransfution-dependent thalassemia, or NTDT. A companion diagnostic, FerriScan, made by Australia-based Resonance Health, also was approved.
-
Hero Nutritionals launches two sugar-free gummy vites for kids
SAN CLEMENTE, Calif. — Hero Nutritionals on Wednesday introduced two sugar-free vitamins to its Yummi Bears line that are naturally sweetened with lo han fruit and inulin fiber.
“Overall the gummy vitamin category is up by 19% year over year, with the new sugar-free trend emerging," stated Claire Polson, national sales and marketing manager for Hero Nutritionals. “Additionally, the supplement alternative sweetener category grew by 10%, with the children’s multivitamin category driving it at 23% growth as compared to 2011.”